Action of nimodipine on sympathomimetic mydriatics in humans. 1992

M Alessandri, and U Pietrini, and E B Bandini, and S Beatrice, and M Fanciullacci
Institute of Internal Medicine and Therapeutics IV, Headache Centre, Florence University, Italy.

In 12 healthy volunteers, the effects of a single oral dose of nimodipine (40 mg) on pupil size and on the mydriasis induced by conjunctival instillation of tyramine and phenylephrine were studied by using a TV monocular infrared pupillometer. Nimodipine alone was unable to modify the pupil area. When compared with placebo, the Ca2+ entry blocker reduced the pupil dilation caused by tyramine, whereas it did not affect the phenylephrine-induced mydriasis. Since tyramine provokes mydriasis by releasing neuronal norepinephrine, a full adrenoceptor agonist, whereas phenylephrine acts only on alpha 1-adrenoceptors insensitive of extracellular Ca2+, the hypothesis may be advanced that a heterogeneous population of alpha-adrenoceptors, located in the human iris dilator muscle and differently sensitive to Ca2+ entry blockade, is responsible for the reduction of the tyramine-induced mydriasis. Apart from this putative mechanism, the results suggest that nimodipine reduces the pupillary response to adrenergic activation in the human eye.

UI MeSH Term Description Entries
D008297 Male Males
D009553 Nimodipine A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure. Admon,Bay e 9736,Brainal,Calnit,Kenesil,Modus,Nimodipin Hexal,Nimodipin-ISIS,Nimodipino Bayvit,Nimotop,Nymalize,Remontal,Bayvit, Nimodipino,Hexal, Nimodipin,Nimodipin ISIS,e 9736, Bay
D009883 Ophthalmic Solutions Sterile solutions that are intended for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS. Eye Drop,Eyedrop,Eyedrops,Ophthalmic Solution,Eye Drops,Drop, Eye,Drops, Eye,Solution, Ophthalmic,Solutions, Ophthalmic
D010656 Phenylephrine An alpha-1 adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent. (R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol,Metaoxedrin,Metasympatol,Mezaton,Neo-Synephrine,Neosynephrine,Phenylephrine Hydrochloride,Phenylephrine Tannate,Neo Synephrine,Tannate, Phenylephrine
D011680 Pupil The aperture in the iris through which light passes. Pupils
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations

Related Publications

M Alessandri, and U Pietrini, and E B Bandini, and S Beatrice, and M Fanciullacci
May 1961, Archives of ophthalmology (Chicago, Ill. : 1960),
M Alessandri, and U Pietrini, and E B Bandini, and S Beatrice, and M Fanciullacci
May 1962, Archives internationales de pharmacodynamie et de therapie,
M Alessandri, and U Pietrini, and E B Bandini, and S Beatrice, and M Fanciullacci
June 1970, The Journal of pharmacy and pharmacology,
M Alessandri, and U Pietrini, and E B Bandini, and S Beatrice, and M Fanciullacci
December 1995, Clinical pharmacology and therapeutics,
M Alessandri, and U Pietrini, and E B Bandini, and S Beatrice, and M Fanciullacci
October 1945, The Journal of pharmacology and experimental therapeutics,
M Alessandri, and U Pietrini, and E B Bandini, and S Beatrice, and M Fanciullacci
June 1956, Archives internationales de pharmacodynamie et de therapie,
M Alessandri, and U Pietrini, and E B Bandini, and S Beatrice, and M Fanciullacci
March 1988, Stroke,
M Alessandri, and U Pietrini, and E B Bandini, and S Beatrice, and M Fanciullacci
January 1992, Eksperimental'naia i klinicheskaia farmakologiia,
M Alessandri, and U Pietrini, and E B Bandini, and S Beatrice, and M Fanciullacci
December 1965, Sheng li xue bao : [Acta physiologica Sinica],
M Alessandri, and U Pietrini, and E B Bandini, and S Beatrice, and M Fanciullacci
June 1971, Japanese journal of pharmacology,
Copied contents to your clipboard!